| 1 |
ClinicalTrials.gov (NCT04890873) ERX1000 - A Phase I, Double-blind, Placebo-controlled, Single and Multiple Oral Dose, Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Male and Female Subjects With Obesity. U.S.National Institutes of Health.
|
